Breaking News Instant updates and real-time market news.

BBRY

New ticker symbol BB

$9.23

0.09 (0.98%)

08:33
09/28/17
09/28
08:33
09/28/17
08:33

BlackBerry says expects Q3, Q4 gross margin above 70% level

  • 28

    Sep

BBRY New ticker symbol BB
$9.23

0.09 (0.98%)

08/07/17
08/07/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. XPO Logistics (XPO) resumed with an Outperform at William Blair. 2. BlackBerry (BBRY) reinstated with a Sell at Goldman Sachs. 3. Brighthouse Financial (BHF) was initiated with a Sell at Citi, a Market Perform at Keefe Bruyette, FBR Capital, and Wells Fargo, a Sector Perform at RBC Capital, and a Neutral at Credit Suisse. 4. Zoetis (ZTS) reinstated with a Neutral at Goldman Sachs. 5. BeiGene (BGNE) initiated with a Buy at Ladenburg. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/11/17
ADAM
08/11/17
NO CHANGE
Target $10
ADAM
Hold
BlackBerry equipped to invest for growth, says Canaccord
Canaccord analyst T. Michael Walkley said Blackberry management gave an upbeat presentation at the firm's conference and explained how the company has completed its transformation into an enterprise software and services company. The analyst noted the company's strong balance sheet, including its cash balance, lead him to believe they have the capital to invest for growth by both hiring and through acquisition. Walkley maintained his Hold rating and $10 price target on Blackberry shares.
09/22/17
BOFA
09/22/17
NO CHANGE
Target $8
BOFA
Underperform
BlackBerry valuation unattractive, says BofA/Merrill
BofA/Merrill analyst Daniel Bartus continues to view BlackBerry's valuation as unattractive saying the company has a long path to profitability, the Enterprise segment valuation is too high, QNX is low growth and at risk of share loss near-term, and Q1 software/services growth was due to a shift from handset related revenues. The analyst raised his price target on BlackBerry to $8 from 7.50 and maintained an Underperform rating on shares.
09/22/17
RBCM
09/22/17
NO CHANGE
Target $9.5
RBCM
Sector Perform
BlackBerry can use $1.6B of cash on acquisitions, says RBC Capital
RBC Capital analyst Paul Treiber says BlackBerry (BBRY) has $2.36B in cash after the $940M award from Qualcomm (QCOM). The company can use up to $1.6B of the cash on acquisitions, which may be accretive to earnings and the stock price, Treiber tells investors in a research note. He fells an acquisition of a company with organic growth above BlackBerry's targeted 10%-15% software growth "would be a tailwind to BlackBerry's organic growth." Treiber expects in-line Q2 results from BlackBerry on September 28 and keeps a Sector Perform rating on the shares.

TODAY'S FREE FLY STORIES

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

07:08
09/24/18
09/24
07:08
09/24/18
07:08
Recommendations
Nightstar Therapeutics analyst commentary  »

Nightstar Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

LGND

Ligand

$260.52

3.01 (1.17%)

07:08
09/24/18
09/24
07:08
09/24/18
07:08
Conference/Events
Ligand management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 06

    Nov

INBK

First Internet Bancorp

$31.05

-0.55 (-1.74%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Conference/Events
First Internet Bancorp management to meet with Craig Hallum »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 15

    Nov

MDWD

MediWound

$6.40

(0.00%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
MediWound awarded additional BARDA contract valued up to $43M »

MediWound announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Oct

SRPT

Sarepta

$147.81

-5.105 (-3.34%)

07:07
09/24/18
09/24
07:07
09/24/18
07:07
Hot Stocks
Sarepta announces FDA lift of clinical hold on DMD micro-dystrophin gene program »

Sarepta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GFN

General Finance Corp

$14.20

(0.00%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
General Finance Corp unit to acquire assets of Instant Storage »

General Finance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUM

Humana

$337.80

0.09 (0.03%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Conference/Events
Humana management to meet with Morgan Stanley »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 28

    Sep

LOOP

Loop Industries

$9.49

0.84 (9.71%)

07:06
09/24/18
09/24
07:06
09/24/18
07:06
Hot Stocks
Loop Industries, Indorama ventures JV to manufacter sustainable polyester resin »

Indorama Ventures Public…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MD

Mednax

$45.60

-1.91 (-4.02%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBP

First BanCorp

$9.17

0.14 (1.55%)

07:05
09/24/18
09/24
07:05
09/24/18
07:05
Conference/Events
First BanCorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

07:05
09/24/18
09/24
07:05
09/24/18
07:05
General news
Oil Action: Front-month WTI crude prices are up 1.6% »

Oil Action: Front-month…

KRYS

Krystal Biotech

$16.88

-0.37 (-2.14%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Initiation
Krystal Biotech initiated  »

Krystal Biotech initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 01

    Oct

  • 03

    Oct

ACRS

Aclaris Therapeutics

$15.18

-0.24 (-1.56%)

07:04
09/24/18
09/24
07:04
09/24/18
07:04
Hot Stocks
Aclaris Therapeutics initiates Phase 3 wart program for A-101 »

Aclaris Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 27

    Nov

T

AT&T

$33.88

0.44 (1.32%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Recommendations
AT&T analyst commentary  »

Deutsche Bank adds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 06

    Nov

  • 12

    Nov

P

Pandora

$9.08

-0.31 (-3.30%)

07:03
09/24/18
09/24
07:03
09/24/18
07:03
Earnings
Pandora backs Q3 revenue view $390M-$405M, consensus $401.45M »

Pandora reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Earnings
Sirius XM backs FY18 guidance for revenue of over $5.7B, consensus $5.76B »

SiriusXM reiterated its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

EPZM

Epizyme

$10.30

-0.1 (-0.96%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Conference/Events
Epizyme to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 02

    Oct

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:02
09/24/18
09/24
07:02
09/24/18
07:02
Hot Stocks
Sirius XM to acquire Pandora in all-stock transaction valuing Pandora at $3.5B »

Sirius XM Holdings (SIRI)…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

MYL

Mylan

$38.98

0.25 (0.65%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Hot Stocks
Mylan, Atomo Diagnostics announce strategic partnership »

Mylan and Atomo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

BLK

BlackRock

$488.00

0.94 (0.19%)

, PAM

Pampa Energia

$37.79

1.09 (2.97%)

07:01
09/24/18
09/24
07:01
09/24/18
07:01
Periodicals
BlackRock, other funds circle troubled Argentine companies, Bloomberg says »

BlackRock (BLK), Carval…

BLK

BlackRock

$488.00

0.94 (0.19%)

PAM

Pampa Energia

$37.79

1.09 (2.97%)

YPF

YPF

$17.04

-0.1 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 17

    Oct

MD

Mednax

$45.60

-1.91 (-4.02%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Upgrade
Mednax rating change  »

Mednax upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

, P

Pandora

$9.08

-0.31 (-3.30%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Hot Stocks
Breaking Hot Stocks news story on Sirius XM, Pandora »

Sirius XM to acquire…

SIRI

Sirius XM

$6.97

-0.05 (-0.71%)

P

Pandora

$9.08

-0.31 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BIO

Bio-Rad

$298.45

-2.74 (-0.91%)

07:00
09/24/18
09/24
07:00
09/24/18
07:00
Recommendations
Bio-Rad analyst commentary  »

Jefferies boosts Bio-Rad…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVP

Avon Products

$2.44

0.035 (1.46%)

, NUS

Nu Skin

$84.46

0.6 (0.72%)

06:58
09/24/18
09/24
06:58
09/24/18
06:58
Upgrade
Avon Products, Nu Skin, Herbalife Nutrition rating change  »

Avon Products upgraded to…

AVP

Avon Products

$2.44

0.035 (1.46%)

NUS

Nu Skin

$84.46

0.6 (0.72%)

HLF

Herbalife Nutrition

$54.98

-0.05 (-0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

IDXG

Interpace Diagnostics

$1.53

-0.11 (-6.71%)

06:57
09/24/18
09/24
06:57
09/24/18
06:57
Hot Stocks
Interpace Diagnostics approved to lauch newest thyroid product, ThyGeNEXT »

Interpace Diagnostics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.